Attainment of Inactive Disease Status Following Initiation of TNF-α Inhibitor Therapy for Juvenile Idiopathic Arthritis: Enthesitis-related Arthritis Predicts Persistent Active Disease

REFERENCES

1. 1.↵
   1. Lovell DJ,
   2. Giannini EH,
   3. Reiff A,
   4. Cawkwell GD,
   5. Silverman ED,
   6. Nocton JJ,
   7. et al.

   Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763–9.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lovell DJ,
   2. Ruperto N,
   3. Goodman S,
   4. Reiff A,
   5. Jung L,
   6. Jarosova K,
   7. et al.

   Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810–20.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Horneff G,
   2. Schmeling H,
   3. Biedermann T,
   4. Foeldvari I,
   5. Ganser G,
   6. Girschick HJ,
   7. et al.

   The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1638–44.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Prince FH,
   2. Twilt M,
   3. ten Cate R,
   4. van Rossum MA,
   5. Armbrust W,
   6. Hoppenreijs EP,
   7. et al.

   Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: The Dutch national register. Ann Rheum Dis 2009;68:635–41.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Giannini EH,
   2. Ilowite NT,
   3. Lovell DJ,
   4. Wallace CA,
   5. Rabinovich CE,
   6. Reiff A,
   7. et al.

   Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2794–804.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Hayward K,
   2. Wallace CA

   . Recent developments in anti-rheumatic drugs in pediatrics: Treatment of juvenile idiopathic arthritis. Arthritis Res Ther 2009;11:216.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Petty RE,
   2. Southwood TR,
   3. Manners P,
   4. Baum J,
   5. Glass DN,
   6. Goldenberg J,
   7. et al.

   International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390–2.

   OpenUrlFREE Full Text
8. 8.↵
   1. Ringold S,
   2. Seidel KD,
   3. Koepsell TD,
   4. Wallace CA

   . Inactive disease in polyarticular juvenile idiopathic arthritis: Current patterns and associations. Rheumatology 2009;48:972–7.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Papsdorf V,
   2. Horneff G

   . Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology 2011;50:214–21.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Cush JJ

    . Early rheumatoid arthritis — Is there a window of opportunity? J Rheumatol Suppl. 2007 Nov;80:1–7.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Albers HM,
    2. Brinkman DM,
    3. Kamphuis SS,
    4. van Suijlekom-Smit LW,
    5. van Rossum MA,
    6. Hoppenreijs EP,
    7. et al.

    Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res 2010;62:204–12.

    OpenUrl
12. 12.↵
    1. Tynjala P,
    2. Vahasalo P,
    3. Tarkiainen M,
    4. Kroger L,
    5. Aalto K,
    6. Malin M,
    7. et al.

    Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): A multicentre randomised open-label clinical trial. Ann Rheum Dis 2011;70:1605–12.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Behrens EM,
    2. Beukelman T,
    3. Cron RQ

    . Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software. J Rheumatol 2007;34:234; reply 235.

    OpenUrlFREE Full Text
14. 14.↵
    1. Wallace CA,
    2. Ruperto N,
    3. Giannini E

    . Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290–4.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Tse SM,
    2. Burgos-Vargas R,
    3. Laxer RM

    . Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum 2005;52:2103–8.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Henrickson M,
    2. Reiff A

    . Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. J Rheumatol 2004;31:2055–61.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Oen K,
    2. Duffy CM,
    3. Tse SM,
    4. Ramsey S,
    5. Ellsworth J,
    6. Chedeville G,
    7. et al.

    Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res 2010;62:527–36.

    OpenUrlCrossRef
18. 18.↵
    1. Cassidy JT,
    2. Petty RE,
    3. Laxer RM,
    4. Lindsley CB

    1. Petty RE,
    2. Cassidy JT

    . Enthesitis-related arthritis (juvenile ankylosing spondylitis). In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology. Philadelphia: Saunders; 2010:272–86.
19. 19.↵
    1. Beukelman T,
    2. Patkar NM,
    3. Saag KG,
    4. Tolleson-Rinehart S,
    5. Cron RQ,
    6. DeWitt EM,
    7. et al.

    2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res 2011;63:465–82.

    OpenUrlCrossRef
20. 20.↵
    1. Giannini EH,
    2. Ruperto N,
    3. Ravelli A,
    4. Lovell DJ,
    5. Felson DT,
    6. Martini A

    . Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202–9.

    OpenUrlPubMed
21. 21.↵
    1. Sherry DD,
    2. Sapp LR

    . Enthesalgia in childhood: Site-specific tenderness in healthy subjects and in patients with seronegative enthesopathic arthropathy. J Rheumatol 2003;30:1335–40.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Horneff G,
    2. De Bock F,
    3. Foeldvari I,
    4. Girschick HJ,
    5. Michels H,
    6. Moebius D,
    7. et al.

    Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): Preliminary data from the German JIA Registry. Ann Rheum Dis 2009;68:519–25.

    OpenUrlAbstract/FREE Full Text